Marion A Coe1, Janine L Pillitteri2, Mark A Sembower3, Karen K Gerlach4, Jack E Henningfield5. 1. Research, Health Policy and Abuse Liability, Pinney Associates, Inc., 4800 Montgomery Lane, Suite 400, Bethesda, MD, 20814, USA. Electronic address: mcoe@pinneyassocaites.com. 2. Pinney Associates, Inc., 201 North Craig Street, Suite 320, Pittsburgh, PA 15213, USA. Electronic address: jpillitt@pinneyassociates.com. 3. Pinney Associates, Inc., 201 North Craig Street, Suite 320, Pittsburgh, PA 15213, USA. Electronic address: msembower@pinneyassociates.com. 4. Pinney Associates, Inc., 201 North Craig Street, Suite 320, Pittsburgh, PA 15213, USA. Electronic address: kgerlach@pinneyassociates.com. 5. Research, Health Policy and Abuse Liability, Pinney Associates, Inc., 4800 Montgomery Lane, Suite 400, Bethesda, MD, 20814, USA; Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: jhenning@pinneyassociates.com.
Abstract
BACKGROUND: Kratom is a South Eastern Asian tree whose leaves are used to make tea-like brews or swallowed in powdered form for various health and well-being reasons including to relieve pain and opioid withdrawal. It is important to learn more about the potential public health impact of kratom in the context of the opioid epidemic. METHODS: An anonymous online survey of kratom users (2867 current users and 157 former users) was conducted in September 2017 through the American Kratom Association and associated social media sites. RESULTS: Kratom was used primarily to relieve pain (endorsed by 48% of respondents), for anxiety, PTSD, or depression (22%), to increase energy or focus (10%) and to help cut down on opioid use and/or relieve withdrawal (10%). Over 90% of respondents who used it in place of opioids indicated that it was helpful to relieve pain, reduce opioid use, and relieve withdrawal. The reported incidence of bad adverse reactions was 13%, and reactions were overwhelmingly mild and self-managed. CONCLUSIONS: Respondents reported using kratom for conditions which often require use of opioids, including pain and reduction of opioid use. The high self-reported efficacy and low incidence of adverse reactions associated with kratom use suggest that it may provide a potential alternative to opioids for some persons even though it has not been evaluated in multi-center clinical trials or approved for any therapeutic purpose. Further study of kratom, including systematic characterization of its safety and efficacy for various conditions is warranted.
BACKGROUND:Kratom is a South Eastern Asian tree whose leaves are used to make tea-like brews or swallowed in powdered form for various health and well-being reasons including to relieve pain and opioid withdrawal. It is important to learn more about the potential public health impact of kratom in the context of the opioid epidemic. METHODS: An anonymous online survey of kratom users (2867 current users and 157 former users) was conducted in September 2017 through the American Kratom Association and associated social media sites. RESULTS:Kratom was used primarily to relieve pain (endorsed by 48% of respondents), for anxiety, PTSD, or depression (22%), to increase energy or focus (10%) and to help cut down on opioid use and/or relieve withdrawal (10%). Over 90% of respondents who used it in place of opioids indicated that it was helpful to relieve pain, reduce opioid use, and relieve withdrawal. The reported incidence of bad adverse reactions was 13%, and reactions were overwhelmingly mild and self-managed. CONCLUSIONS: Respondents reported using kratom for conditions which often require use of opioids, including pain and reduction of opioid use. The high self-reported efficacy and low incidence of adverse reactions associated with kratom use suggest that it may provide a potential alternative to opioids for some persons even though it has not been evaluated in multi-center clinical trials or approved for any therapeutic purpose. Further study of kratom, including systematic characterization of its safety and efficacy for various conditions is warranted.
Authors: Laura Flores-Bocanegra; Huzefa A Raja; Tyler N Graf; Mario Augustinović; E Diane Wallace; Shabnam Hematian; Joshua J Kellogg; Daniel A Todd; Nadja B Cech; Nicholas H Oberlies Journal: J Nat Prod Date: 2020-06-29 Impact factor: 4.050
Authors: Albert Garcia-Romeu; David J Cox; Kirsten E Smith; Kelly E Dunn; Roland R Griffiths Journal: Drug Alcohol Depend Date: 2020-02-03 Impact factor: 4.492
Authors: Samuel Obeng; Shyam H Kamble; Morgan E Reeves; Luis F Restrepo; Avi Patel; Mira Behnke; Nelson J-Y Chear; Surash Ramanathan; Abhisheak Sharma; Francisco León; Takato Hiranita; Bonnie A Avery; Lance R McMahon; Christopher R McCurdy Journal: J Med Chem Date: 2019-12-27 Impact factor: 7.446
Authors: Yuchen Zhou; Steven Ramsey; Davide Provasi; Amal El Daibani; Kevin Appourchaux; Soumen Chakraborty; Abhijeet Kapoor; Tao Che; Susruta Majumdar; Marta Filizola Journal: Biochemistry Date: 2020-12-04 Impact factor: 3.162
Authors: Jawad Ahmad; Joseph A Odin; Paul H Hayashi; Robert J Fontana; Hari Conjeevaram; Bharathi Avula; Ikhlas A Khan; Huiman Barnhart; Raj Vuppalanchi; Victor J Navarro Journal: Drug Alcohol Depend Date: 2020-11-23 Impact factor: 4.492